Vimarsana
Biggest News Aggregation in the World

Page 11 - Double Blind News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Double Blind. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Double Blind Today - Breaking & Trending Today

SEL-212 Shows Significant Response Rates, sUA Reductions in Patients with Gout - Vimarsana News

SEL-212 Shows Significant Response Rates, sUA Reductions in Patients with Gout

Investigators believe targeted immunomodulation with SEL-212 may have the potential to introduce a new uricase-based therapy for patients with gout refractory to conventional treatment.

Homeopathy for ADHD Study: Research Paper Retracted - Vimarsana News

Homeopathy for ADHD Study: Research Paper Retracted

Homeopathy for ADHD study paper receives a retraction from Pediatrics Research, citing biased studies and invalid results.

On the move: latest sector appointments - Vimarsana News

On the move: latest sector appointments

New arts sector appointments at The Australian Ballet, Hazelhurst Arts Centre, ACMI and more.

Study: URTI symptoms reduced with palmitoylethanolamide (PEA) supplementation - Vimarsana News

Study: URTI symptoms reduced with palmitoylethanolamide (PEA) supplementation

An industry funded study concludes the branded palmitoylethanolamide (PEA) ingredient ‘Levagen+’ is safe and effective in reducing the incidence and symptoms associated with upper respiratory tract infections (URTIs).

Study: URTI symptoms reduced with PEA Levagen+ - Vimarsana News

Study: URTI symptoms reduced with PEA Levagen+

An industry funded study concludes the branded palmitoylethanolamide (PEA) ingredient ‘Levagen+’ is safe and effective in reducing the incidence and symptoms associated with upper respiratory tract infections (URTIs).